Total soluble and endogenous secretory receptor for advanced glycation end products as predictive biomarkers of coronary heart disease risk in patients with type 2 diabetes: an analysis from the CARDS trial.

Total soluble and endogenous secretory receptor for advanced glycation end products as predictive biomarkers of coronary heart disease risk in patients with type 2 diabetes: an analysis from the CARDS trial.

OBJECTIVE: Circulating levels of soluble receptor for advanced glycation end products (sRAGE) likely comprise both a secreted isoform (esRAGE) and wild-type RAGE cleaved from the cell membrane. Both sRAGE and esRAGE have been proposed as biomarkers of cardiovascular disease (CVD), but prospective d...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखकों:	Colhoun, H, Betteridge, D, Durrington, P, Hitman, G, Neil, A, Livingstone, S, Charlton-Menys, V, Bao, W, Demicco, D, Preston, G, Deshmukh, H, Tan, K, Fuller, J
स्वरूप:	Journal article
भाषा:	English
प्रकाशित:	2011

समान संसाधन

Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the Collaborative Atorvastatin Diabetes Study (CARDS).
द्वारा: Colhoun, H, और अन्य
प्रकाशित: (2009)

C-reactive Protein and Amyloid A as Predictors of Cardiovascular Events in Type 2 Diabetes in CARDS
द्वारा: Charlton-Menys, V, और अन्य
प्रकाशित: (2009)

Erratum: Apolipoproteins, cardiovascular risk and statin response in type 2 diabetes: The Collaborative Atorvastatin Diabetes Study (CARDS)
द्वारा: Charlton-Menys, V, और अन्य
प्रकाशित: (2009)

Apolipoproteins, cardiovascular risk and statin response in type 2 diabetes: the Collaborative Atorvastatin Diabetes Study (CARDS).
द्वारा: Charlton-Menys, V, और अन्य
प्रकाशित: (2009)

Targets of statin therapy: LDL cholesterol, non-HDL cholesterol, and apolipoprotein B in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS).
द्वारा: Charlton-Menys, V, और अन्य
प्रकाशित: (2009)

Analysis of efficacy and safety in patients aged 65-75 years at randomization: Collaborative Atorvastatin Diabetes Study (CARDS).
द्वारा: Neil, H, और अन्य
प्रकाशित: (2006)

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.
द्वारा: Colhoun, H, और अन्य
प्रकाशित: (2004)

Effect of atorvastatin in patients 65 years of age with type 2 diabetes: Subgroup analysis from the collaborative atorvastatin diabetes study (CARDS)
द्वारा: DeMicco, D, और अन्य
प्रकाशित: (2005)

Change in Lp-PLA2 With Risk Change on Statin Therapy in the Collaborative Atorvastatin Diabetes Study (CARDS)
द्वारा: Betteridge, D, और अन्य
प्रकाशित: (2009)

Cost-effectiveness of primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes: results from the Collaborative Atorvastatin Diabetes Study (CARDS).
द्वारा: Raikou, M, और अन्य
प्रकाशित: (2007)

Rapid emergence of effect of atorvastatin on cardiovascular outcomes in the Collaborative Atorvastatin Diabetes Study (CARDS).
द्वारा: Colhoun, H, और अन्य
प्रकाशित: (2005)

Safety of atorvastatin in the collaborative AtoRvastatin diabetes study (CARDS)
द्वारा: Newman, C, और अन्य
प्रकाशित: (2006)

The safety and tolerability of atorvastatin 10 mg in the Collaborative Atorvastatin Diabetes Study (CARDS).
द्वारा: Newman, C, और अन्य
प्रकाशित: (2008)

Stroke prediction and stroke prevention with atorvastatin in the Collaborative Atorvastatin Diabetes Study (CARDS).
द्वारा: Hitman, G, और अन्य
प्रकाशित: (2007)

Effect of atorvastatin on stroke in the collaborative atorvastatin diabetes study (CARDS): Factors predictive of the risk of stroke
द्वारा: Newman, C, और अन्य
प्रकाशित: (2005)

Baseline characteristics in the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with Type 2 diabetes.
द्वारा: Thomason, M, और अन्य
प्रकाशित: (2004)

The effect of atorvastatin therapy on tumour necrosis factor-α and vascular adhesion molecules in patients with type 2 diabetes mellitus with no prior history of coronary heart disease
द्वारा: Soedamah-Muthu, S, और अन्य
प्रकाशित: (2011)

Cost-effectiveness of atorvastatin (10mg) in patients with type 2 diabetes without coronary heart disease: CARDS trial analysis and extrapolation
द्वारा: Raikou, M, और अन्य
प्रकाशित: (2005)

Design of the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with type 2 diabetes.
द्वारा: Colhoun, H, और अन्य
प्रकाशित: (2002)

Effect of atorvastatin on stroke in patients with type 2 diabetes: factors predicting the risk of stroke in the Collaborative Atorvastatin Diabetes Study (CARDS)
द्वारा: Hitman, G, और अन्य
प्रकाशित: (2005)

The effect of atorvastatin on serum lipids, lipoproteins and NMR spectroscopy defined lipoprotein subclasses in type 2 diabetic patients with ischaemic heart disease.
द्वारा: Soedamah-Muthu, S, और अन्य
प्रकाशित: (2003)

Bone-Targeting Endogenous Secretory Receptor for Advanced Glycation End Products Rescues Rheumatoid Arthritis
द्वारा: Tatsuo Takahashi, और अन्य
प्रकाशित: (2013-06-01)

Genome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy: importance of Lp(a)
द्वारा: Harshal A. Deshmukh, और अन्य
प्रकाशित: (2012-05-01)

Soluble RAGE but not endogenous secretory RAGE is associated with albuminuria in patients with type 2 diabetes
द्वारा: Morcos Michael, और अन्य
प्रकाशित: (2007-03-01)

Differing predictive relationships between baseline LDL-C, systolic blood pressure, and cardiovascular outcomes
द्वारा: Deedwania, PC, और अन्य
प्रकाशित: (2016)

1 h Postload Glycemia Is Associated with Low Endogenous Secretory Receptor for Advanced Glycation End Product Levels and Early Markers of Cardiovascular Disease
द्वारा: Antonino Di Pino, और अन्य
प्रकाशित: (2019-08-01)

Concentration of Endogenous Secretory Receptor for Advanced Glycation End Products and Matrix Gla Protein in Controlled and Uncontrolled Type 2 Diabetes Mellitus Patients
द्वारा: Dwi Yuniati Daulay, और अन्य
प्रकाशित: (2013-04-01)

Serum Level of Soluble Receptor for Advanced Glycation End Products Is Associated with A Disintegrin And Metalloproteinase 10 in Type 1 Diabetes.
द्वारा: Alan C H Lee, और अन्य
प्रकाशित: (2015-01-01)

Status report of lipid-lowering trials in diabetes.
द्वारा: Betteridge, D, और अन्य
प्रकाशित: (2000)

Effects of methanolic extracts from edible plants on endogenous secretory receptor for advanced glycation end products induced by the high glucose incubation in human endothelial cells
द्वारा: Yoshinori Okada, और अन्य
प्रकाशित: (2015-01-01)

Increased C-reactive protein levels in overweight and obese women taking exogenous hormones: the United Kingdom Women's Heart Study (UKWHS).
द्वारा: Kwok, S, और अन्य
प्रकाशित: (2009)

Enhancement of pea protein solubility and thermal stability for acidic beverage applications via endogenous Maillard-induced glycation and chromatography purification
द्वारा: Alissa A. Schneider, और अन्य
प्रकाशित: (2023-01-01)

Inverse association between glycated albumin and insulin secretory function may explain higher levels of glycated albumin in subjects with longer duration of diabetes.
द्वारा: Yong-ho Lee, और अन्य
प्रकाशित: (2014-01-01)

Comparison of the risk of fatal coronary heart disease in treated xanthomatous and non-xanthomatous heterozygous familial hypercholesterolaemia: a prospective registry study.
द्वारा: Neil, H, और अन्य
प्रकाशित: (2003)

Non-coronary heart disease mortality and risk of fatal cancer in patients with treated heterozygous familial hypercholesterolaemia: a prospective registry study.
द्वारा: Neil, H, और अन्य
प्रकाशित: (2005)

Endogenous advanced glycation end products in the pathogenesis of chronic diabetic complications
द्वारा: Misganaw Asmamaw Mengstie, और अन्य
प्रकाशित: (2022-09-01)

Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD
द्वारा: Katherine A. Pratte, और अन्य
प्रकाशित: (2021-04-01)

Endogenous Secretory RAGE as a Novel Biomarker for Metabolic Syndrome and Cardiovascular Diseases
द्वारा: Hidenori Koyama, और अन्य
प्रकाशित: (2007-01-01)

Endogenous and Exogenous Regulatory Signaling in the Secretory Pathway: Role of Golgi Signaling Molecules in Cancer
द्वारा: Simona Del Giudice, और अन्य
प्रकाशित: (2022-03-01)

Soluble Receptor for Glycation End-products Concentration Increases Following the Treatment of Severe Diabetic Ketoacidosis
द्वारा: William H. Hoffman, और अन्य
प्रकाशित: (2020-06-01)